VVD-214

VVD-214
Clinical data
Drug class	WRN helicase inhibitor
Identifiers
	IUPAC name N-[(E,1S)-1-cyclopropyl-3-methylsulfonylprop-2-enyl]-2-(1,1-difluoroethyl)-4-phenoxypyrimidine-5-carboxamide;
CAS Number	3026500-20-6;
PubChem CID	170717998;
ChemSpider	129389587;
Chemical and physical data
Formula	C20H21F2N3O4S
Molar mass	437.46 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C1=NC=C(C(=N1)OC2=CC=CC=C2)C(=O)N[C@H](/C=C/S(=O)(=O)C)C3CC3)(F)F;
	InChI InChI=1S/C20H21F2N3O4S/c1-20(21,22)19-23-12-15(18(25-19)29-14-6-4-3-5-7-14)17(26)24-16(13-8-9-13)10-11-30(2,27)28/h3-7,10-13,16H,8-9H2,1-2H3,(H,24,26)/b11-10+/t16-/m1/s1; Key:UWPFUBNCDABUEE-SIFUEBAJSA-N;

Drug classWRN helicase inhibitor

CAS Number

3026500-20-6

PubChem CID

170717998

ChemSpider

129389587

VVD-214 (RO7589831) is a drug which acts as an inhibitor of the enzyme WRN helicase. It is being researched for the treatment of microsatellite instability high forms of cancer.^[1]^[2]

[1]

[2]

Related Articles